CBDMD, INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$19.19M
Revenue
$-2.04M
Net Income
-
EPS (Diluted)
-
Free Cash Flow
Profitability
Gross Margin
62.37%
Operating Margin
-11.27%
Net Profit Margin
-10.63%
EBITDA
$-2.16M
Returns & Efficiency
Return on Assets (ROA)
-19.59%
Return on Equity (ROE)
-28.24%
Gross Profit
$11.97M
Operating Income
$-2.16M
Financial Health
Total Assets
$10.42M
Total Debt
-
Debt to Equity
0.44x
Current Ratio
2.05
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
-
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
8845 RED OAK BOULEVARD
CHARLOTTE, NC 28217 |
| Phone | 704-445-3060 |
| Incorporated | NC, US |
| EIN | 473414576 |
| Fiscal Year End | 0930 |
| Shares Outstanding | 4.55M |
| Stockholders' Equity | $7.23M |
| Cash & Equivalents | $2.26M |
Recent Filings
View All
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2026-03-04
Local
424B4
Prospectus (Rule 424b4)
Prospectus filed under Rule 424(b)(4)
Filed: 2026-03-04
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-02-17
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-02-12
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2026-01-20
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-12-19
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-15
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-02-25
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-02-13
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2025-01-27
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-12-18
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-15
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-02-14
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
62.4%
Operating Margin
-11.3%
Net Margin
-10.6%
ROE
-28.2%
ROA
-19.6%
Leverage & Liquidity
Debt to Equity
0.44
Current Ratio
2.05
Total Debt
-
Total Assets
$10.42M
Stockholders' Equity
$7.23M
Income Statement (FY 2025)
Revenue
$19.19M
Gross Profit
$11.97M
Operating Income
$-2.16M
Net Income
$-2.04M
EPS (Diluted)
-
Cash Flow (FY 2025)
Free Cash Flow
-
Cash & Equivalents
$2.26M
Revenue Growth
-1.5%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...